Andrew Regan

CIK: 0001991325

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (45.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (20.8%)

Compensation grants

Other (G, F, J, C, D, …)8 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CDT

CDT Equity Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (24 total)

CDT
CDT Equity Inc.
Oct 23, 2026
Other(J)
Direct
499.6K shares-
CDT
CDT Equity Inc.
Oct 22, 2026
Other(J)
Indirect
1.3M shares-
CDT
CDT Equity Inc.
Aug 28, 2026
Other(J)
Indirect
543.7K shares-
CDT
CDT Equity Inc.
Aug 28, 2026
In-the-Money(X)
Pre-Funded Warrants
Indirect
543.7K shares at avg. $0.00-
CDT
CDT Equity Inc.
Aug 28, 2026
Sale(S)
Indirect
29 shares-
CDT
CDT Equity Inc.
Jul 30, 2026
Other(J)
Pre-Funded Warrants
Indirect
5.4M shares at avg. $0.00-
CDT
CDT Equity Inc.
May 13, 2026
Award(A)
Indirect
100K shares at avg. $1.90$190K
CDT
CDT Equity Inc.
Mar 24, 2026
Award(A)
Indirect
147.4K shares-
CDT
CDT Equity Inc.
Mar 24, 2026
Conversion(C)
Pre-Funded Warrants
Indirect
147.4K shares at avg. $0.00-
CDT
CDT Equity Inc.
Dec 8, 2025
Award(A)
Indirect
224.8K shares at avg. $1.79$402K
CDT
CDT Equity Inc.
Sep 19, 2025
Award(A)
Direct
1.1M shares at avg. $0.69$769K
CDT
CONDUIT PHARMACEUTICALS INC.
Jun 3, 2025
Award(A)
Indirect
154.8K shares at avg. $3.23$500K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 17, 2024
Sale(S)
Indirect
1.5M shares at avg. $0.26$391K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 16, 2024
Sale(S)
Indirect
10.2M shares at avg. $0.32$3.2M
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 15, 2024
Sale(S)
Indirect
1M shares at avg. $0.25$248K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 12, 2024
Sale(S)
Indirect
1.4M shares at avg. $0.25$343K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 11, 2024
Sale(S)
Indirect
300K shares at avg. $0.29$87K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 11, 2024
Sale(S)
Indirect
583K shares at avg. $0.30$173K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 10, 2024
Sale(S)
Indirect
150K shares at avg. $0.33$50K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 9, 2024
Sale(S)
Indirect
77.7K shares at avg. $0.44$34K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 8, 2024
Sale(S)
Indirect
35.9K shares at avg. $0.51$18K
CDT
CONDUIT PHARMACEUTICALS INC.
Jul 3, 2024
Sale(S)
Indirect
1K shares at avg. $0.64$640
CDT
CONDUIT PHARMACEUTICALS INC.
Jun 14, 2024
Other(J)
Indirect
1.1M shares-
CDT
CONDUIT PHARMACEUTICALS INC.
Jun 14, 2024
Other(J)
Indirect
1.1M shares-

		Type	Shares	Price		Ownership
Oct 23, 2026	CDT CDT Equity Inc.	Other(J)	499,616	-	$0	Direct
Oct 22, 2026	CDT CDT Equity Inc.	Other(J)	1,347,616	-	$0	Indirect
Aug 28, 2026	CDT CDT Equity Inc.	Other(J)	543,683	-	$0	Indirect
Aug 28, 2026	CDT CDT Equity Inc.	In-the-Money(X) Pre-Funded Warrants	543,683	$0.00	-	Indirect
Aug 28, 2026	CDT CDT Equity Inc.	Sale(S)	29	-	$0	Indirect
Jul 30, 2026	CDT CDT Equity Inc.	Other(J) Pre-Funded Warrants	5,436,830	$0.00	-	Indirect
May 13, 2026	CDT CDT Equity Inc.	Award(A)	100,000	$1.90	$190,000	Indirect
Mar 24, 2026	CDT CDT Equity Inc.	Award(A)	147,401	-	$0	Indirect
Mar 24, 2026	CDT CDT Equity Inc.	Conversion(C) Pre-Funded Warrants	147,401	$0.00	-	Indirect
Dec 8, 2025	CDT CDT Equity Inc.	Award(A)	224,800	$1.79	$402,392	Indirect
Sep 19, 2025	CDT CDT Equity Inc.	Award(A)	1,120,000	$0.69	$768,656	Direct
Jun 3, 2025	CDT CONDUIT PHARMACEUTICALS INC.	Award(A)	154,799	$3.23	$500,001	Indirect
Jul 17, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,514,100	$0.26	$391,092	Indirect
Jul 16, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	10,244,392	$0.32	$3,246,448	Indirect
Jul 15, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,005,200	$0.25	$248,385	Indirect
Jul 12, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,389,820	$0.25	$343,425	Indirect
Jul 11, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	300,000	$0.29	$87,000	Indirect
Jul 11, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	582,952	$0.30	$173,253	Indirect
Jul 10, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	150,000	$0.33	$50,070	Indirect
Jul 9, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	77,681	$0.44	$33,853	Indirect
Jul 8, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	35,923	$0.51	$18,321	Indirect
Jul 3, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Sale(S)	1,000	$0.64	$640	Indirect
Jun 14, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Other(J)	1,100,000	-	$0	Indirect
Jun 14, 2024	CDT CONDUIT PHARMACEUTICALS INC.	Other(J)	1,100,000	-	$0	Indirect

1-24 of 24 transactions

About Regan Andrew

Regan Andrew (SEC CIK 0001991325) files insider reports with the SEC as Chief Executive Officer of CDT Equity Inc. (CDT).

Signal8 holds 8 ownership filings by Regan Andrew, all Form 4s, filed between Sep 19, 2024 and Oct 27, 2026. Those filings report 24 transactions, from Jun 14, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Regan Andrew's filings is in NAPLES, FL.

Recent filings by Regan Andrew

Oct 23, 2026: Other transaction of CDT shares (Form 4, code J).
Oct 22, 2026: Other transaction of CDT shares (Form 4, code J).
Aug 28, 2026: Other transaction of CDT shares (Form 4, code J).
Aug 28, 2026: Option exercise of CDT derivative securities (Form 4, code X).
Aug 28, 2026: Open-market sale of CDT shares (Form 4, code S).

Other insiders filing for CDT Equity Inc. (CDT)

Manoira Corp, 10% Owner
Taylor Mark Andrew, 10% Owner
Farley Chele Chiavacci, Director
Bligh James, Interim CFO
Fry Simon Jeremy, Director
Lewis-Hall Freda C, Director

How to read Form 4 transaction codes